Open AccessS777 Tofacitinib for the Treatment of Ulcerative Colitis: Up to 7.8 Years of Safety Data from Global Clinical Trials
Author(s) -
William J. Sandborn,
Geert DʼHaens,
Bruce E. Sands,
Remo Panaccione,
Siew C. Ng,
Nervin Lawendy,
Nicole Kulisek,
Xiang Guo,
Rajiv Mundayat,
Chinyu Su,
Julián Panés
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000776640.47467.7e
Subject(s) - tofacitinib , medicine , adverse effect , ulcerative colitis , cohort , incidence (geometry) , gastroenterology , surgery , rheumatoid arthritis , disease , physics , optics